Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Wellcome Trust Case Control Consortium Resource Report Resource Website 100+ mentions |
Wellcome Trust Case Control Consortium (RRID:SCR_001973) | WTCCC | data or information resource | Consortium of 50 research groups across the UK to harness the power of newly-available genotyping technologies to improve our understanding of the aetiological basis of several major causes of global disease. The consortium has gathered genotype data for up to 500,000 sites of genome sequence variation (single nucleotide polymorphisms or SNPs) in samples ascertained for the disease phenotypes. Analysis of the genome-wide association data generated has lead to the identification of many SNPs and genes showing evidence of association with disease susceptibility, some of which will be followed up in future studies. In addition, the Consortium has gained important insights into the technical, analytical, methodological and biological aspects of genome-wide association analysis. The core of the study comprised an analysis of 2,000 samples from each of seven diseases (type 1 diabetes, type 2 diabetes, coronary heart disease, hypertension, bipolar disorder, rheumatoid arthritis and Crohn's disease). For each disease, the case samples have been ascertained from sites widely distributed across Great Britain, allowing us to obtain considerable efficiencies by comparing each of these case populations to a common set of 3,000 nationally-ascertained controls also from England, Scotland and Wales. These controls come from two sources: 1,500 are representative samples from the 1958 British Birth Cohort and 1,500 are blood donors recruited by the three national UK Blood Services. One of the questions that the WTCCC study has addressed relates to the relative merits of these alternative strategies for the generation of representative population cohorts. Genotyping for this main Case Control study was conducted by Affymetrix using the (commercial) Affymetrix 500K chip. As part of this study a total of 17,000 samples were typed for 500,000 SNPs. There are two additional components to the study. First, the WTCCC award is part-funding a study of host resistance to infectious diseases in African populations. The same approach has been used to type 2,000 cases of tuberculosis (TB) and 2,000 cases of malaria, as well as 2,000 shared controls. As well as addressing diseases of major global significance, and extending WTCCC coverage into the area of infectious disease, the inclusion of samples of African origin has obvious benefits with respect to methodological aspects of genome-wide association analysis. Second, the WTCCC has, for four additional diseases (autoimmune thyroid disease, breast cancer, ankylosing spondylitis, multiple sclerosis), completed an analysis of 15,000 SNPs designed to represent a large proportion of the known non-synonymous coding SNPs across the genome. This analysis has been performed at the WTSI using a custom Infinium chip (Illumina). Data release The genotypic data of the control samples (1958 British Birth Cohort and UK Blood Service) and from seven diseases analyzed in the main study are now available to qualified researchers. Summary genotype statistics for these collections are available directly from the website. Access to the individual-level genotype data and summary genotype statistics is by application to the Consortium Data Access Committee (CDAC) and approval subject to a Data Access Agreement. WTCCC2: A further round of GWA studies were funded in April 2008. These include 15 WTCCC-collaborative studies and 12 independent studies be supported totaling approximately 120,000 samples. Many of the studies represent major international collaborative networks that have together assembled large sample collections. WTCCC2 will perform genome-wide association studies in 13 disease conditions: Ankylosing spondylitis, Barrett's oesophagus and oesophageal adenocarcinoma, glaucoma, ischaemic stroke, multiple sclerosis, pre-eclampsia, Parkinson's disease, psychosis endophenotypes, psoriasis, schizophrenia, ulcerative colitis and visceral leishmaniasis. WTCCC2 will also investigate the genetics of reading and mathematics abilities in children and the pharmacogenomics of statin response. Over 60,000 samples will be analyzed using either the Affymetrix v6.0 chip or the Illumina 660K chip. The WTCCC2 will also genotype 3,000 controls each from the 1958 British Birth cohort and the UK Blood Service control group, and the 6,000 controls will be genotyped on both the Affymetrix v6.0 and Illumina 1.2M chips. WTCCC3: The Wellcome Trust has provided support for a further round of GWA studies in January 2009. These include 5 WTCCC-collaborative studies to be carried out in WTCCC3 and 5 independent studies, across a range of diseases. Many of the studies represent major international collaborative networks that have together assembled large sample collections. WTCCC3 will perform genome-wide association studies in the following 4 disease conditions: primary biliary cirrhosis, anorexia nervosa, pre-eclampsia in UK subjects, and the interactions between donor and recipient DNA related to early and late renal transplant dysfunction. The WTCCC3 will also carry out a pilot in a study of the genetics of host control of HIV-1 infection. Over 40,000 samples will be analyzed using the Illumina 660K chip. The WTCCC3 will utilize the 6,000 control genotypes generated by the WTCCC2. | gene, genomic, genetics, microarray, genome-wide association study, snp, genome-wide association, blood, dna, genotype, variation, genome, sequence variant, copy number variation, genetic variation, phenotype, disease |
is related to: Psychiatric Genomics Consortium has parent organization: Wellcome Trust Sanger Institute; Hinxton; United Kingdom |
Bipolar disorder, Coronary artery disease, Crohn's disease, Rheumatoid arthritis, Type 1 diabetes, Type 2 diabetes, Hypertension, Control, Multiple sclerosis, Breast cancer, Ankylosing spondylitis, Autoimmune thyroid disease, Malaria, Tuberculosis, Inflammatory bowel disease, Barrett's esophagus, Esophageal adenocarcinoma, Glaucoma, Ischemic stroke, Pre-eclampsia, Parkinson's disease, Psychosis endophenotypes, Psoriasis, Schizophrenia, Ulcerative colitis, Visceral leishmaniasis, Primary biliary cirrhosis, Anorexia nervosa, Human immunodeficiency virus, Renal transplant dysfunction, Diabetes | Wellcome Trust ; Bill and Melinda Gates Foundation ; Wellcome Trust Sanger Institute; Hinxton; United Kingdom |
PMID:17554300 | Access to summary data and individual-level genotype data is available by application to the Wellcome Trust Case Control Consortium Data Access Committee. Access to data will be granted to qualified investigators for appropriate use. | nif-0000-10551 | SCR_001973 | Wellcome Trust Case-Control Consortium (WTCCC) | 2026-02-07 02:05:38 | 212 | ||||
|
University of Michigan Human Breast Cancer Cell Lines Resource Report Resource Website 1+ mentions |
University of Michigan Human Breast Cancer Cell Lines (RRID:SCR_000542) | University of Michigan Human Breast Cancer Cell Lines | biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 1, 2023. Asterand, Inc., the Detroit-based supplier of human tissue products and services, announces the distribution of eleven breast cancer cell lines, derived at the University of Michigan. The University has agreed to license the marketing of the breast cancer cell lines, known as the SUM lines, through Asterand in an effort to provide an exceptional tool to a broad base of researchers studying the disease. There are an estimated 1.2 million new diagnoses worldwide of breast cancer each year. The cell lines can be used to study all aspects of breast cancer biology, from new drug target identification to cell signaling to effects of novel drugs on cellular proliferation. | cell line, breast cancer |
is related to: Asterand has parent organization: University of Michigan Medical School; Michigan; USA |
Breast cancer | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_84393 | SCR_000542 | University of Michigan SUM-LINES, University of Michigan Human Breast Cancer Cell Lines (SUM-LINES) | 2026-02-07 02:14:11 | 3 | ||||||
|
Biobank Graz Resource Report Resource Website |
Biobank Graz (RRID:SCR_004245) | Biobank Graz | biomaterial supply resource, material resource | Biobank Graz is a non-profit central Medical University of Graz (MUG) service facility that provides the logistics and infrastructure to optimally support MUG research teams in the collection, processing and storage of biological samples and their associated data. In the course of this, special attention is given to sample and data quality and to the protection of the individual rights of patients. Samples from selected patients at the Graz LKH-University Clinical Centre, who have signed an informed consent declaration, are deposited in Biobank Graz. This means that excess tissue and blood samples are collected and placed in storage. The samples are harvested in the course of routine interventions undertaken by the different departments and institutes of the Graz LKH-University Clinical Centre and approved for use in research projects only after the completion of all necessary laboratory and histopathological analyses. No additional material is removed: in other words, there are no associated drawbacks whatsoever for the patients involved. Biobank Graz operates a quality management system according to ISO 9001:2008 and offers the following services for the processing and storage of biological samples and the handling of data: * Consistently high sample quality through the processing of samples using standardized methods in accordance with written working instructions (SOPs) * Efficient use of resources through the building of shared infrastructure and the development of optimized processes * A high degree of reliability provided by the storage of samples in 24/7 - monitored storage systems. * Processing and storage of all data in accordance with data protection legislation. Biobank Graz comprises both population-based and disease-focused collections of biological materials. It currently contains approx. 3.8 mio samples from approx. 1.2 mio patients representing a nonselected patient group characteristic of central Europe. Because the Institute of Pathology was, until 2003, the exclusive pathology service provider for major parts of the province of Styria, including its capital Graz (population approx. 1.2 mio people), samples from all human diseases, treated by surgery or diagnosed by biopsy, are included in the collection at their natural frequency of occurrence and thus represent cancers and non-cancerous diseases from all organs, and from all age groups. The scientific value of the existing tissue collection is, thus, not only determined by its size and technical homogeneity (all samples have been processed in a single institute under constant conditions for more than 20 years), but also by its population-based character. These features provide ideal opportunities for epidemiological studies and allow the validation of biomarkers for the identification of specific diseases and determination of their response to treatment. Prospectively collected tissues, blood samples and clinical data comprise, on the one hand, randomly selected samples from all diseases and patient groups to provide sufficient numbers of samples for the evaluation of the disease-specificity of any gene or biomarker. On the other hand, Biobank Graz adopts a disease-focused approach for selected diseases (such as breast, colon and liver cancers as well as some metabolic diseases) through the collection of a range of different human biological samples of highest quality and detailed clinical follow-up data. Graz Medical University established the Biobank to provide improved and sustainable access to biological samples and related (clinical) data both for its own academic research and for external research projects of academic and industrial partners. It is a major interest of the university to initiate co-operative research projects. Biological samples and data are available to external institutions performing high-quality research projects which comply with the Biobank''s ethical and legal framework according to the access rules (Contact: COO Karine Sargsyan, MD, PhD). | tissue, blood, dna, rna, serum, plasma, bodily fluid, urine, cryopreserved, formalin fixed paraffin embedded, csf, frozen, disease, population, patient, healthy, normal, clinical, patient, healthy, normal, disease, cancer, metabolic disease, breast cancer, colon cancer, liver cancer, clinical data, cerebral spinal fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Medical University of Graz; Graz; Austria |
All, Patient, Healthy, Normal, Disease, Cancer, Metabolic disease, Breast cancer, Colon cancer, Liver cancer | Public: Graz Medical University established the Biobank to provide improved and sustainable access to biological samples and related (clinical) data both for its own academic research and for external research projects of academic and industrial partners. It is a major interest of the university to initiate co-operative research projects. Biological samples and data are available to external institutions performing high-quality research projects which comply with the Biobank''s ethical and legal framework according to the access rules. | nlx_25894 | SCR_004245 | 2026-02-07 02:14:17 | 0 | |||||||
|
LIBRO-1: Individualized prediction and prevention of breast cancer Resource Report Resource Website 1+ mentions |
LIBRO-1: Individualized prediction and prevention of breast cancer (RRID:SCR_006036) | LIBRO-1 | biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented August 23, 2016. Libro-1 is a study with the overall aim to identify prognostic factors for breast cancer. The study comprise women in the Stockholm-Gotland region that were diagnosed with breast cancer between the years 2001-2008. Register data (tumor characteristics and treatment), lifestyle factors and blood samples have been collected from the participants. | breast, cancer, tumor, treatment, woman, female, lifestyle, prognostic factor, prediction, prevention |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Karolisnka Biobank |
Breast cancer | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_151436 | SCR_006036 | KI Biobank - LIBRO-1, KI Biobank: LIBRO-1, LIBRO-1: Individualized prediction prevention of breast cancer | 2026-02-07 02:14:11 | 1 | ||||||
|
AdaptiveCrawler Resource Report Resource Website |
AdaptiveCrawler (RRID:SCR_000573) | AdaptiveCrawler | web application, software resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 9,2022. A web crawler that can intelligently acquire social media content on the Internet to meet the specific online data source acquisition needs of cancer researchers. | web crawler, acquire social media content on Internet, cancer research, |
is listed by: OMICtools has parent organization: Oak Ridge National Laboratory |
Cancer, Breast cancer, Lung cancer | PMID:24078710 | THIS RESOURCE IS NO LONGER IN SERVICE | OMICS_01170 | SCR_000573 | Adaptive Crawler, Smart Web Crawler | 2026-02-10 09:54:21 | 0 | |||||
|
DCI Tissue and Blood Procurement Shared Resource Resource Report Resource Website |
DCI Tissue and Blood Procurement Shared Resource (RRID:SCR_004116) | DCI Tissue Bank | biomaterial supply resource, tissue bank, material resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 16, 2013. Over 10,000 patient consents, 5,000 banking events, and 40,000 biospecimens have been processed to date with storage of both formalin fixed paraffin embedded (FFPE) tissue and frozen tissue located within multiple freezers spanning temperatures in the range of -80 degrees to -180 degrees C depending on protocol requirements. Considerable effort continues to be expended to assure compliance with IRB, NIH and HIPAA best practices and guidelines on banking human tissues. The biorepository in place today is the result of the combined efforts of the Duke Cancer Institute (DCI) Breast SPORE, DCI Shared Resource for Tissue and Blood Procurement, and the Duke University School of Medicine Research Foundation (DUSOM-RF). The DCI and the School of Medicine Research Foundation (SOMRF) have funded the collection of frozen and fixed tissues, both malignant and benign, under an ?????????????????excess tissue????????????????? protocol that utilizes freshly excised tissue that is available for research after the needs of the pathologic workup are met. This program procures tissues from many anatomic sites including breast. Recently Duke''s Institute of Genome Science & Policy (IGSP), under the direction of Drs. Geoff Ginsburg and Tom Burke, initiated a blood collection program that spans several departments and institutes. The Breast SPORE blood collection program served as the pilot for this much larger effort. The Breast SPORE tissue and blood collection effort utilizes much of the same infrastructure and personnel that are also supported by the DCI, SOMRF, and IGSP. | blood, tissue, cancer, biospecimen, formalin fixed paraffin embedded tissue, frozen tissue, malignant, benign, breast tissue, breast cancer, tumor, frozen, paraffin, malignant tissue, benign tissue |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Duke Cancer Institute |
Cancer, Breast cancer, Malignant tumor, Benign tumor | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_19619 | http://www.cancer.duke.edu/modules/SPORE50/index.php?id=5 | SCR_004116 | Duke Cancer Institute Tissue and Blood Procurement Shared Resource, DCI Tissue Bank, Duke Cancer Institute Tissue Bank, DCI Tissue Blood Procurement Shared Resource, Duke Cancer Institute Tissue Blood Procurement Shared Resource | 2026-02-11 10:56:48 | 0 | |||||
|
Ludwig Boltzman Tumour Bank Resource Report Resource Website |
Ludwig Boltzman Tumour Bank (RRID:SCR_004322) | Ludwig Boltzmann Tumor Bank | biomaterial supply resource, tissue bank, material resource | As a basis for the experimental cluster projects, and for further future projects a collection of various biological specimens of cancer patients shall be established. All participating Ludwig Boltzmann Institutes (LBIs) are supplying biological specimens from tumor patients and clinical documentation. At the LBI for Gynecology and Gynecologic Oncology a tumor bank for biological specimens from gynecologic cancer patients already exists. All the procedures for sample processing and storage are well established. Existing equipment for storing tissue specimens at -196 degrees C can be used. Materials from the following malignant diseases are collected: Breast cancer Colorectal cancer Neuroendocrine tumors (NET) (Small cell lung cancer (SCLC) and Carcinoid tumors) Types of biological materials: Tissue (fresh frozen) Bone marrow Blood (serum/plasma/cell fractions) Pleural effusions Ascitic fluids Sputum Bronchial lavage Stool The biological specimens are initially processed at the respective LBIs or at their connected lab facilities. Enrichment of blood samples for disseminated tumor cells is done at the LBI for Gynecology and Gynecologic oncology. Long time storage of all materials is done at appropriate temperatures at the same institution. This LBI also coordinates the logistics. All relevant sample-specific and clinical data are surveyed at the respective LBIs and stored centralized in an on-line data bank in anonymized form, respecting all relevant regulations on data protection and security. | tissue, bone marrow, blood, serum, plasma, cell fraction, pleural effusion, ascitic fluid, sputum, bronchial lavage, stool, tumor cell, fresh frozen, frozen, tumor, cancer, breast cancer, colorectal cancer, neuroendocrine tumor, small cell lung cancer, carcinoid tumor, gynecologic cancer, clinical data, bodily fluid |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Ludwig Boltzmann Cluster Translationale Onkologie |
Tumor, Cancer, Breast cancer, Colorectal cancer, Neuroendocrine tumor, Small cell lung cancer, Carcinoid tumor, Gynecologic cancer | nlx_33431 | SCR_004322 | Ludwig Boltzmann Gesellschaft Tumor Bank | 2026-02-11 10:56:52 | 0 | |||||||
|
Canadian Breast Cancer Foundation Tumor Bank Resource Report Resource Website 1+ mentions |
Canadian Breast Cancer Foundation Tumor Bank (RRID:SCR_004214) | CBCF TB | biomaterial supply resource, tissue bank, material resource | THIS RESOURCE IS NO LONGER IN SERVICE, documented May 18, 2022. A tumor bank that provides a large collection of cancer specimens, from breast and other cancers, annotated with clinical information. The CBCF TB enables researchers to address unanswered questions concerning the prognosis and treatment of breast cancer and other cancers. The CBCF TB website is also directed to participants interested in donating tumor tissue or blood. Biological specimens such as blood, urine, bone marrow, and ascites (fluid that sometimes collects in the abdomen) contain genetic information, just as tumor tissue does. These samples can be used in studies that may help researchers see how people with certain genetic make-ups respond to certain treatments. It can also explain why different people have different health problems. CBCF TB, formerly ARTB, was created by a merger of components of two existing Tumor-banking initiatives, the CLS Repository in Calgary and the Tumor bank of the PolyomX Program in Edmonton. | clinical information, clinical |
is listed by: One Mind Biospecimen Bank Listing is related to: Canadian Tumour Repository Network has parent organization: Canadian Breast Cancer Foundation |
Breast cancer, Tumor, Cancer | Canadian Breast Cancer Foundation ; Alberta Cancer Foundation |
THIS RESOURCE IS NO LONGER IN SERVICE | nlx_143637 | http://www.abtumorbank.com/ | SCR_004214 | Canadian Breast Cancer Foundation Alberta Research Tumor Bank, ARTB, CBCF Tumor Bank, Alberta Research Tumor Bank | 2026-02-11 10:56:50 | 3 | ||||
|
National Surgical Adjuvant Breast and Bowel Project Tissue Bank Resource Report Resource Website |
National Surgical Adjuvant Breast and Bowel Project Tissue Bank (RRID:SCR_004506) | NSABP Tissue Bank | biomaterial supply resource, tissue bank, material resource | The NSABP (National Surgical Adjuvant Breast and Bowel Project) Tissue Bank is the central repository of tissue samples (stained and unstained slides, tissue blocks, and frozen tissue specimens) collected from clinical trials conducted by the NSABP. The main scientific aim of the NSABP Division of Pathology is to develop clinical context-specific prognostic markers and predictive markers that predict response to or benefit from specific therapeutic modality. To achieve this aim, the laboratory collects the tumor and adjacent normal tissues from cancer patients enrolled into the NSABP trials through its membership institutions, and maintain these valuable materials with clinical follow-up information and distribute them to qualified approved investigators. Currently, specimens from more than 90,000 cases of breast and colon cancer are stored and maintained at the bank. Paraffin embedded tumor specimens are available from NSABP trials. We currently do not bank frozen tissues. All blocks are from patients enrolled in prospective NSABP treatment protocols and complete clinical follow up information as well as demographic information is available. Depending on the project, unstained tissue sections of 4-micrometer thickness, tissue microarrays, or stained slides are provided to the investigators in a blinded study format. Any investigators with novel projects that conform to the research goals of NSABP may apply for the tissue. Please refer to the NSABP Tissue Bank Policy to determine if your project conforms to these goals. Priority is given to NSABP membership institutions who regularly submit tissue blocks. | clinical, clinical data, demographic data, tumor, specimen, breast tissue, bowel tissue, tumor tissue, adjacent normal tissue, tissue, stained slide, unstained slide, tissue block, paraffin embedded, tissue microarray, cancer, breast cancer, colon cancer, normal |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Pittsburgh; Pennsylvania; USA |
Cancer, Breast cancer, Colon cancer | NCI | Public: Any investigators with novel projects that conform to the research goals of NSABP may apply for the tissue. Priority is given to NSABP membership institutions who regularly submit tissue blocks. | nlx_48875 | http://www.nsabp.pitt.edu/NSABP_Pathology.asp#2.%20Tissue%20Bank | SCR_004506 | National Surgical Adjuvant Breast Bowel Project Tissue Bank | 2026-02-11 10:56:54 | 0 | ||||
|
UAB SPORE Biorepository Banks Resource Report Resource Website |
UAB SPORE Biorepository Banks (RRID:SCR_004419) | biomaterial supply resource, tissue bank, material resource | A biomaterial supply resource which stores and provides ovarian, breast, pancreatic, and cervical tissue samples and fluids to cancer researchers. The UAB Tissue Collection and Banking Facility collects tissue samples for the UAB Ovarian, Breast, Pancreatic, and Cervix SPORE banks. Samples from the former Ovarian SPORE bank are available to UAB Cancer Center members via the Tissue Procurement Shared Facility, and to other researchers via the Cooperative Human Tissue Network. | breast cancer, tissue, blood, cervical cancer, pancreatic cancer, ovarian cancer, tissue bank, biorepository |
is listed by: One Mind Biospecimen Bank Listing is related to: UAB Comprehensive Cancer Center Tissue Procurement Shared Facility is related to: Cooperative Human Tissue Network is related to: UAB Comprehensive Cancer Center Tissue Procurement Shared Facility has parent organization: University of Alabama at Birmingham School of Medicine; Alabama; USA |
breast cancer, cervical cancer, pancreatic cancer, ovarian cancer | Available to the research community | nlx_143728 | http://www.dopm.uab.edu/breast-spore/resources_for_researchers.htm | SCR_004419 | UAB SPORE Breast Cancer Tissue Bank | 2026-02-11 10:56:53 | 0 | ||||||
|
Tumorbank Basel Foundation Resource Report Resource Website |
Tumorbank Basel Foundation (RRID:SCR_004962) | Tumorbank Basel Foundation | biomaterial supply resource, tissue bank, material resource | Since 1995 the Tumorbank Basel Foundation (German: Stiftung Tumorbank Basel) is a non-for-profit foundation acting in cancer translation research. The purpose of the Tumorbank Basel Foundation is to support in promoting optimization of decision making process for the management of solid cancer personalized treatment modalities to the benefit of the patient. Our Aims: * Acquisition and storage of biological material and clinical data of patients suffering of solid cancer diseases in particular breast and prostate cancer. * Promoting and supporting cancer research using the acquired material and data for clinical studies and translational research. * The development of molecular tumor analyses / tools for cancer patients and the performance of the resulting diagnostic services for personalized treatment modalities. The Tumorbank Basel Foundation has acquired * Data about more than 10''000 breast cancer patients * Data comprise clinical and pathological (histology & IHC) characteristics and biochemical (continuous quantified protein expression levels) features, which are available for almost all samples as well as clinical follow-ups now available for more than 2''000 patients * The RNA expression level of 65 genes has been assessed in >800 samples by Real-Time PCR (317 retrospectively in cases with follow-up, the remaining on a routine basis, prospectively since 2004) The Tumorbank Basel Foundation is storing in Freezers at - 80 degrees C * Ca. 6''000 fresh frozen tissue samples of breast cancer patients * Ca. 9''000 particulate fractions (cytosol / membrane) of all samples analyzed * Ca. 1''000 paired non-malignant adjacent tissue material samples * More than 1''000 extracted RNA samples of good quality * Serum and plasma collection from patients has been started since 2005 All data are stored in a relational SQL data bank using an application. The Tumorbank Basel Foundation is collaborating with several pathology institutes allowing to perform studies correlating results obtained from fresh frozen and paired paraffin embedded tissue samples. The Tumorbank Basel Foundation has started a prostate carcinoma project in Collaboration with the ZeTuP (www.zetup.ch) and pathology institute of St. Gallen. Fresh frozen samples of more than 150 prostate carcinoma patients have been collected and are under investigation. | tissue, tumor tissue, serum, plasma, rna, particulate fraction, clinical data, frozen, fresh frozen, paraffin embedded, cancer, breast cancer, prostate cancer, solid cancer disease | is listed by: One Mind Biospecimen Bank Listing | Cancer, Breast cancer, Prostate cancer, Solid cancer disease | Collaborators: The Tumorbank Basel Foundation is collaborating with several pathology institutes allowing to perform studies correlating results obtained from fresh frozen and paired paraffin embedded tissue samples. | nlx_143986 | SCR_004962 | Stiftung Tumorbank Basel | 2026-02-11 10:57:01 | 0 | ||||||
|
Susan G. Komen Tissue Bank Resource Report Resource Website 1+ mentions |
Susan G. Komen Tissue Bank (RRID:SCR_004708) | KTB | biomaterial supply resource, tissue bank, material resource | The goals of the Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center are to acquire biomolecule and tissue specimens from the entire continuum of breast development: puberty to menopause and to make these specimens or the digital data derived from them available and accessible to researchers across the globe. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Indiana University; Indiana; USA has parent organization: Susan G. Komen for the Cure |
Breast cancer | nlx_70500 | SCR_004708 | Tissue Bank at the IU Simon Cancer Center, Susan G. Komen for the Cure Tissue Bank, Komen Tissue Bank | 2026-02-11 10:56:57 | 6 | ||||||||
|
South Carolina Biorepository System Resource Report Resource Website |
South Carolina Biorepository System (RRID:SCR_005034) | SCBS | biomaterial supply resource, tissue bank, material resource | The South Carolina Biorepository System (SCBS), directed by Dr. Phil Buckhaults, School of Medicine, is a statewide tissue bank working with health care facilities across South Carolina to collect tumor and matched normal tissue samples from patients with cancer, and providing these samples to researchers statewide. All specimens are de-identified to protect patient privacy, but are annotated with essential, detailed clinical data. Currently, the SCBS inventory includes specimens from the leading types of cancers in South Carolina: breast, colorectal, lung, and prostate, as well as many other cancer sites. The ultimate goal is to improve the lives of cancer patients and their families. | tissue, normal, tumor, tumor tissue, matched normal tissue, cancer, breast cancer, colorectal cancer, lung cancer, prostate cancer, clinical data |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of South Carolina; South Carolina; USA |
Cancer, Breast cancer, Colorectal cancer, Lung cancer, Prostate cancer | Public (South Carolina): The South Carolina Biorepository System (SCBS) is a statewide tissue bank working with health care facilities across South Carolina to collect tumor and matched normal tissue samples from patients with cancer, And providing these samples to researchers statewide. | nlx_98613 | SCR_005034 | 2026-02-11 10:57:03 | 0 | |||||||
|
British Columbia Breast Cancer Tumour Bank Resource Report Resource Website |
British Columbia Breast Cancer Tumour Bank (RRID:SCR_006671) | BREAST-TTR | biomaterial supply resource, tissue bank, material resource | The Molecular Oncology department hosts the breast cancer tumour tissue repository (BREAST-TTR), a project within the agency-wide tumour tissue repository. The BREAST-TTR comprises several important banks of breast tissues, contemporaneous as well as archival. The main banks are: * 3000 frozen breast cancers, linked to 15 year outcomes data from the BCCA Breast Cancer Outcomes Unit. This archival bank consists of frozen tissue, DNA and RNA, and a tissue microarray of the cases. * Live-cryopreserved cancers. At present around 50 individual cases of metastatic breast cancer, with tumour material cryopreserved for subsequent cell culture/xenograft work. * Comptemporary bank. Between the TTR in Victoria and the accrual site in Vancouver, approximately 1300 contemporaneous (within last 4 years) breast cancers with matched normal DNA and outcomes linkages. | breast cancer, tumor, tissue, breast tissue, frozen tissue, dna, rna, tissue microarray, live-cryopreserved cancer, metastatic breast cancer, cryopreserved, matched normal dna |
is listed by: One Mind Biospecimen Bank Listing has parent organization: BC Cancer Agency |
Breast cancer, Tumor, Metastatic breast cancer, Matched normal | nlx_50799 | http://molonc.bccrc.ca/?page_id=421 | SCR_006671 | British Columbia Breast Tumour Bank, Breast Cancer Tumour Tissue Repository, British Columbia Breast Cancer Tumour Tissue Repository, British Columbia Breast Cancer Tumor Tissue Repository | 2026-02-11 10:57:23 | 0 | ||||||
|
Eligibility Feature Hierarchy Resource Report Resource Website |
Eligibility Feature Hierarchy (RRID:SCR_010314) | ELIG | ontology, controlled vocabulary, data or information resource | A set of 1,437 eligibility features that were organized into a feature hierarchy using 80 breast cancer trials. | owl | is listed by: BioPortal | Breast cancer | nlx_157395 | SCR_010314 | 2026-02-11 10:58:17 | 0 | ||||||||
|
LINCS Joint Project - Breast Cancer Network Browser Resource Report Resource Website 1+ mentions |
LINCS Joint Project - Breast Cancer Network Browser (RRID:SCR_016181) | LJP-BCNB, LJP, BCNB | data access protocol, service resource, software resource, web service | Interactive on line tool where signatures are tagged with user selected metadata and external transcript signatures are projected onto network. Browser to visualize signatures from breast cancer cell lines treated with single molecule perturbations. | breast, cancer, tissue, cluster, drug, perturbation, cell, line, gene, expression |
is related to: L1000 Characteristic Direction Signature Search Engine is related to: LINCS Project |
Breast cancer | NHLBI U54 HL127624; NHLBI U54 HL127365; NHGRI U54 HG006093; NCI U54 CA189201 |
PMID:29084964 | Free, Freely available | https://github.com/MaayanLab/LJP | SCR_016181 | LINCS Joint Project, Breast Cancer Network Browser | 2026-02-11 10:59:20 | 1 | ||||
|
GSE4922 Resource Report Resource Website 100+ mentions |
GSE4922 (RRID:SCR_003557) | GSE4922 | data or information resource, data set | Curated data set of a study that investigated the expression profiles of 347 primary invasive breast tumors on Affymetrix microarrays. Three separate breast cancer cohorts were analyzed: 1) Uppsala (n=249), 2) Stockholm (n=58), 3) Singapore (n=40). The Uppsala and Singapore data can be accessed in GSE4922. The Stockholm cohort data can be accessed at GEO Series GSE1456. | adult human, expression profile, breast |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Breast cancer, Tumor | Free, Public | nlx_157796 | SCR_003557 | 2026-02-11 10:56:45 | 110 | |||||||
|
Congressionally Directed Medical Research Program Resource Report Resource Website 10+ mentions |
Congressionally Directed Medical Research Program (RRID:SCR_006456) | CDMRP | nonprofit organization | Fund the best research to eradicate diseases and support the warfighter to benefit the American Public. They promote innovative research, recognizing untapped opportunities, creating partnerships, and guarding the public trust. Research Program topics include: * Amyotrophic Lateral Sclerosis * Autism * Bone Marrow Failure * Breast Cancer * Defense Medical Research and Development Program * Duchenne Muscular Dystrophy * Gulf War Illness * Lung Cancer * Multiple Sclerosis * Neurofibromatosis * Ovarian Cancer * Peer Reviewed Cancer * Peer Reviewed Medical * Peer Reviewed Orthopaedic * Prostate Cancer * Psychological Health / Traumatic Brain Injury * Spinal Cord Injury * Tuberous Sclerosis Complex | grant, funding, one mind tbi, one mind ptsd, medical, medical research, psychological health, orthopedic, peer review, biomedical |
is related to: NIDDK Information Network (dkNET) has parent organization: U.S. Department of Defense |
Amyotrophic Lateral Sclerosis, Autism, Bone marrow failure, Breast cancer, Duchenne muscular dystrophy, Gulf War Illness, Lung cancer, Multiple Sclerosis, Neurofibromatosis, Ovarian cancer, Cancer, Prostate cancer, Traumatic brain injury, Spinal cord injury, Tuberous sclerosis complex | United States Department of Defense | nif-0000-00443, grid.496791.4, Crossref funder ID: 100000090, ISNI: 0000 0000 9367 6288, Wikidata: Q45134126 | https://ror.org/03g2zjp07 | SCR_006456 | DOD CDMRP | 2026-02-07 02:07:15 | 48 | |||||
|
Cancer Registry of Norway Resource Report Resource Website 1+ mentions |
Cancer Registry of Norway (RRID:SCR_008879) | Cancer Registry of Norway | institution | Comprises 3 registries of cancer patients in Norway: the Incidence Registry, the Clinical Registry and Cancer Statistics. The Incidence Registry contains the basic data items collected from clinicians and pathologists, as well as from administrative discharge and mortality sources. It is updated continuously with information on both new cases, as well as cases diagnosed in previous years. All medical doctors in the country are instructed by law to notify new cancer cases. Clinical Registries: Registration of treatment and follow-up of Norwegian cancer patients. Clinical registries comprehensive registration schemes dedicated to specific cancers have been established to include detailed information on diagnostic measures, therapy, and follow-up. Cancer Statistics: Database of cancer statistics. The Cancer Registry of Norway is maintained by the Institute of Population-based Cancer Research and established in 1951. It is one of the oldest national cancer registries in the world. This, combined with the unique personal identification number used in Norway, makes the Cancer Registry''s data suitable, also internationally; by establishing new knowledge through research and spreading information on cancer. | is parent organization of: Janus Serum Bank | Cancer, Breast cancer, Cervical cancer, Colorectal cancer, Prostate cancer, Lung cancer, Hereditary cancer, Pediatric solid tumor, Ovarian cancer, Malignant melanoma | grid.418941.1, ISNI: 0000 0001 0727 140X, nlx_149447 | https://ror.org/03sm1ej59 | SCR_008879 | Cancer Registry of Norway: Institute of Population-based Cancer Research | 2026-02-07 02:07:33 | 6 | |||||||
|
Orion Resource Report Resource Website 10+ mentions |
Orion (RRID:SCR_003911) | Orion | commercial organization | A globally operating Finnish developer, manufacturer and marketer of human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. They are continuously developing new drugs and treatment methods. Pharmaceutical RD focuses on central nervous system drugs, oncology and critical care drugs, and Easyhaler pulmonary drugs. | pharmaceutical, drug, diagnostic test, diagnostic, central nervous system, drug, oncology, critical care, pulmonary, central nervous system drug, pulmonary drug, cancer, veterinary drug, medicine, clinical, hygiene monitoring |
is related to: MIP-DILI is related to: NEWMEDS is related to: ORBITO is related to: PREDECT |
Cancer, Asthma, Alzheimer's disease, Parkinson's disease, Breast cancer, Prostate cancer | nlx_158257 | SCR_003911 | Orion Corporation, Orion Pharma | 2026-02-07 02:06:31 | 34 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
